Searching the Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Gaucher Disease (GD) type 3 is a neurological form of a multisystemic autosomal recessive disorder belonging to the group of lysosomal storage diseases. Causal mutations in the glucocerebrosidase 1 (GBA1) commonly lead to abnormal protein and GD, heterozygosity is a genetic risk factor for Parkinson's disease. This work describes the use of a non-integrative approach using Sendai Virus delivery to establish induced Pluripotent Stem Cells (iPSCs) from fibroblasts from a GD type 3 patient. Differentiation of iPSCs can be employed to generate a variety of complex cell types with a high degree of genetic complexity that would otherwise be unattainable.
Pubmed ID: 31678773
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets HSP90B1
View all literature mentionsThis polyclonal targets Human SOX17
View all literature mentionsThis monoclonal targets SOX-2 clone 10H9.1
View all literature mentionsThis monoclonal targets OCT-4 (POU5F1)
View all literature mentionsThis polyclonal targets Human/Mouse Brachyury Affinity Purified Ab
View all literature mentionsThis polyclonal targets Human Otx2 Affinity Purified Ab
View all literature mentionsThis monoclonal targets NEW NANOG clone 7F7.1
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentions